These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
603 related articles for article (PubMed ID: 33824205)
21. Fusobacterium nucleatum: an emerging bug in colorectal tumorigenesis. Bashir A; Miskeen AY; Bhat A; Fazili KM; Ganai BA Eur J Cancer Prev; 2015 Sep; 24(5):373-85. PubMed ID: 25569450 [TBL] [Abstract][Full Text] [Related]
22. Effect of a bacteriocin-producing Lawrence GW; McCarthy N; Walsh CJ; Kunyoshi TM; Lawton EM; O'Connor PM; Begley M; Cotter PD; Guinane CM Gut Microbes; 2022; 14(1):2100203. PubMed ID: 35877697 [TBL] [Abstract][Full Text] [Related]
23. Detection of Fusobacterium nucleatum in stool and colonic tissues from Norwegian colorectal cancer patients. Tunsjø HS; Gundersen G; Rangnes F; Noone JC; Endres A; Bemanian V Eur J Clin Microbiol Infect Dis; 2019 Jul; 38(7):1367-1376. PubMed ID: 31025134 [TBL] [Abstract][Full Text] [Related]
24. Highly sensitive stool DNA testing of Fusobacterium nucleatum as a marker for detection of colorectal tumours in a Japanese population. Suehiro Y; Sakai K; Nishioka M; Hashimoto S; Takami T; Higaki S; Shindo Y; Hazama S; Oka M; Nagano H; Sakaida I; Yamasaki T Ann Clin Biochem; 2017 Jan; 54(1):86-91. PubMed ID: 27126270 [TBL] [Abstract][Full Text] [Related]
25. Modulation of the Host Cell Transcriptome and Epigenome by Fusobacterium nucleatum. Despins CA; Brown SD; Robinson AV; Mungall AJ; Allen-Vercoe E; Holt RA mBio; 2021 Oct; 12(5):e0206221. PubMed ID: 34700376 [TBL] [Abstract][Full Text] [Related]
26. Association of Fusobacterium nucleatum infection with colorectal cancer in Chinese patients. Li YY; Ge QX; Cao J; Zhou YJ; Du YL; Shen B; Wan YJ; Nie YQ World J Gastroenterol; 2016 Mar; 22(11):3227-33. PubMed ID: 27004000 [TBL] [Abstract][Full Text] [Related]
27. Association between Bacteroides fragilis and Fusobacterium nucleatum infection and colorectal cancer in Vietnamese patients. Nguyen Duy T; Le Huy H; Đao Thanh Q; Ngo Thi H; Ngo Thi Minh H; Nguyen Dang M; Le Huu S; Ngo Tat T Anaerobe; 2024 Aug; 88():102880. PubMed ID: 38942229 [TBL] [Abstract][Full Text] [Related]
28. Proteomic characterization of outer membrane vesicles from gut mucosa-derived fusobacterium nucleatum. Liu J; Hsieh CL; Gelincik O; Devolder B; Sei S; Zhang S; Lipkin SM; Chang YF J Proteomics; 2019 Mar; 195():125-137. PubMed ID: 30634002 [TBL] [Abstract][Full Text] [Related]
29. [The Relationship of Enterotoxigenic Bacteroides fragilis and Fusobacterium nucleatum Intestinal Colonization with Colorectal Cancer: A Case-Control Study Performed with Colon Biopsies]. Öztürk Bakar Y; Demiryas S; Ceylan Kılınçarslan A; Demirci M; Kepil N; Bakar MT; Taner Z; Tokuç E; Ziyad MA; Taşçı İ; Kocazeybek BS; Bahar Tokman H Mikrobiyol Bul; 2023 Jul; 57(3):353-364. PubMed ID: 37462300 [TBL] [Abstract][Full Text] [Related]
30. Circulating Bacterial DNA in Colorectal Cancer Patients: The Potential Role of Koliarakis I; Lagkouvardos I; Vogiatzoglou K; Tsamandouras I; Intze E; Messaritakis I; Souglakos J; Tsiaoussis J Int J Mol Sci; 2024 Aug; 25(16):. PubMed ID: 39201711 [TBL] [Abstract][Full Text] [Related]
31. Fusobacterium nucleatum and T Cells in Colorectal Carcinoma. Mima K; Sukawa Y; Nishihara R; Qian ZR; Yamauchi M; Inamura K; Kim SA; Masuda A; Nowak JA; Nosho K; Kostic AD; Giannakis M; Watanabe H; Bullman S; Milner DA; Harris CC; Giovannucci E; Garraway LA; Freeman GJ; Dranoff G; Chan AT; Garrett WS; Huttenhower C; Fuchs CS; Ogino S JAMA Oncol; 2015 Aug; 1(5):653-61. PubMed ID: 26181352 [TBL] [Abstract][Full Text] [Related]
32. Fusobacterium and Escherichia: models of colorectal cancer driven by microbiota and the utility of microbiota in colorectal cancer screening. Leung A; Tsoi H; Yu J Expert Rev Gastroenterol Hepatol; 2015 May; 9(5):651-7. PubMed ID: 25582922 [TBL] [Abstract][Full Text] [Related]
33. Colorectal cancer: the facts in the case of the microbiota. Clay SL; Fonseca-Pereira D; Garrett WS J Clin Invest; 2022 Feb; 132(4):. PubMed ID: 35166235 [TBL] [Abstract][Full Text] [Related]
34. Association of Fusobacterium nucleatum with immunity and molecular alterations in colorectal cancer. Nosho K; Sukawa Y; Adachi Y; Ito M; Mitsuhashi K; Kurihara H; Kanno S; Yamamoto I; Ishigami K; Igarashi H; Maruyama R; Imai K; Yamamoto H; Shinomura Y World J Gastroenterol; 2016 Jan; 22(2):557-66. PubMed ID: 26811607 [TBL] [Abstract][Full Text] [Related]
35. The Role of Fecal Liu K; Yang X; Zeng M; Yuan Y; Sun J; He P; Sun J; Xie Q; Chang X; Zhang S; Chen X; Cai L; Xie Y; Jiao X Dis Markers; 2021; 2021():1171239. PubMed ID: 34853619 [TBL] [Abstract][Full Text] [Related]
36. Fusobacterium nucleatum, a key pathogenic factor and microbial biomarker for colorectal cancer. Wang N; Fang JY Trends Microbiol; 2023 Feb; 31(2):159-172. PubMed ID: 36058786 [TBL] [Abstract][Full Text] [Related]
39. Fusobacterium nucleatum promotes tumor progression in KRAS p.G12D-mutant colorectal cancer by binding to DHX15. Zhu H; Li M; Bi D; Yang H; Gao Y; Song F; Zheng J; Xie R; Zhang Y; Liu H; Yan X; Kong C; Zhu Y; Xu Q; Wei Q; Qin H Nat Commun; 2024 Feb; 15(1):1688. PubMed ID: 38402201 [TBL] [Abstract][Full Text] [Related]
40. Fusobacterium nucleatum in colorectal carcinoma tissue and patient prognosis. Mima K; Nishihara R; Qian ZR; Cao Y; Sukawa Y; Nowak JA; Yang J; Dou R; Masugi Y; Song M; Kostic AD; Giannakis M; Bullman S; Milner DA; Baba H; Giovannucci EL; Garraway LA; Freeman GJ; Dranoff G; Garrett WS; Huttenhower C; Meyerson M; Meyerhardt JA; Chan AT; Fuchs CS; Ogino S Gut; 2016 Dec; 65(12):1973-1980. PubMed ID: 26311717 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]